| Literature DB >> 32877951 |
Gudiya Gupta1, Mohd Aftab Siddiqui1, Mohd Muazzam Khan1, Mohd Ajmal1, Rabiya Ahsan1, Md Azizur Rahaman2, Md Afroz Ahmad1, Md Arshad3, Mohammad Khushtar1.
Abstract
Myricetin is a member of the group of flavonoids called flavonols. Myricetin is obtained from various fruit, vegetables, tea, berries and red wine. Myricetin is characterized by the pysrogallol B-ring, and the more hydroxylated structure is known to be capable for its increased biological properties compared with other flavonols. Myricetin is produced by the Myricaceae, Anacardiaceae, Polygonaceae, Pinaceae and Primulacea families. It is soluble in organic solvent such as ethanol, DMSO (dimethyl sulfoxide), and dimethyl formamide (DMF). It is sparingly soluble in aqueous buffers. Myricetin shows its various pharmacological activities including antioxidant, anti-amyloidogenic, antibacterial, antiviral, antidiabetic, anticancer, anti-inflammatory, anti-epileptic and anti-ulcer. This review article focuses on pharmacological effects of Myricetin on different diseases such as osteoporotic disorder, anti-inflammatory disorder, alzheimer's disease, anti-epileptic, cancer, cardiac disorder, diabetic metabolic disorder, hepatoprotective disorder and gastro protective disorder. Thieme. All rights reserved.Entities:
Mesh：
Substances：
Year: 2020 PMID： 32877951 DOI： 10.1055/a-1224-3625
Source DB: PubMed Journal: Drug Res (Stuttg) ISSN： 2194-9379